Herbal Psychotropics. Part 3: Focus on Kava,Valerian,and Melatonin

American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.

Armitage, R. , Yonkers, K. , Cole, D. , & Rush, A.J. (1997). A multicenter, double-blind comparison of the effects of nefazadone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients. Journal of Clinical Psychopharmacology , 17, 161-168.

Barrett, B. , Kiefer, D. , & Rabago, D. (1999). Assessing the risks and benefits of herbal medicine: An overview of the scientific evidence. Alternative Therapies in Health and Medicine, 5 (4), 40-49.

Chan, T.Y. , Tang, C.H. , & Critchley, J.A. (1995). Poisoning due to an over-the-counter hypnotic, Sleep-Qik (hyoscine, cyproheptadine, valerian) Postgraduate Medical Journal, 71, 227-228.

Cupp, M.J. (1999). Herbal remedies: Adverse effects and drug interactions . American Family Physician, 59, 239-1245.

Fugh-Berman, A. , & Cott, J.M. (1999). Dietary supplements and natural products as psychotherapeutic agents. Psychosomatic Medicine, 61, 712-728.

Heinze, H.J. , Munthe, T.F. , Steitz, J. , & Matzke, M. (1994). Pharmacopsychological effects of oxazepam and kava extract in a visual search paradigm assessed with event-related potentials . Pharmacopsychiatry, 27, 224-230.

Houghton, P.J. (1999). The scientific basis for the reputed activity of valerian. Journal of Pharmacy and Pharmacology, 51, 505-512.

Jean-Louis, G. , von Gizycki, H. , & Zizi, F. (1999). Predictors of subjective sleepiness induced by melatonin administration. Journal of Psychosomatic Research , 47, 355-358.

Kirkwood, C.K. (1999). Management of insomnia. Journal of the American Pharmacy Association (Washington), 39, 688-698.

Kuhlman, J. , Berger, W. , Podzuweit, H. , & Schmidt, U. (1999). The influence of valerian treatment on reaction time, alertness, and concentration in volunteers. Pharmacopsychiatry , 32, 235-241.

The mainstreaming of alternative medicine. (2000, May). Consumer Reports, 17-25.

Matsumoto, M. (1999). The hypnotic effects of melatonin treatment on diurnal sleep in humans. Psychiatry and Clinical Neurosciences , 53, 243-245.

Miller, L.G. (1998). Herbal medicinals: Selected clinical considerations focusing on known or potential drug-drug interactions. Archives of Internal Medicine, 158, 2200-2211.

Muller, B. , & Komorek, R. (1999). Treatment with kava—the root to combat stress . Wiener Medizinische Wochenschrift, 149 (8-10), 197-201.

Ortiz, J.G. , Nieves-Natal, J. , & Chavez, P. (1999). Effects of valeriana officinalis extracts on [3H] flunitrazepam binding, synapsomal [3H] GABA uptake and hippocampal [3H] GABA release. Neurochemical Research, 24, 1373-1378.

Piper methysticum (Kava Kava). Alternative Medicine Review , 3 (6), 458-460.

Pittler, M.H. , & Ernst, E. (2000). Efficacy of kava extract for treating anxiety: Systematic review and meta analysis. Journal of Clinical Psychopharmacology , 20, 84-89.

Santos, M.S. , Ferreira, F. , Cunha, A.P. , Carvalho, A.P. , Ribeiro, C.F. , & Macedo, T. (1994). Synaptosomal GABA release as influenced by valerian root extract: Involvement of the GABA carrier. Archives Internationales de Pharmacodynamie et de Therapie, 327, 220-231.

Scherer, J. (1998). Kava kava extract in anxiety disorders: An outpatient observational study. Advances in Therapy, 15, 261-269.

Schmitz, M. , & Jackel, M. (1998). Comparative study for assessing quality of life of patients with exogenous sleep disorders treated with a hops-valerian preparation and a benzodiazepine drug. Wiener Medizinische Wochenschrift , 148, 291-298.

Shilo, L. , Dagan, Y. , Smorjik, Y. , Weinberg, U. , Dolev, S. , Komptel, B. , & Shenkman, L. (2000). Effect of melatonin on sleep quality of COPD intensive care patients: A pilot study. Chronobiology International , 17, 71-76.

Singh, Y.N. (1992). Kava: An overview. Journal of Ethnopharmacology, 37 (1), 13-45.

Strahl, S. , Ehret, V. , Dahm, H.H. , & Maier, K.P. (1998). Necrotizing hepatitis after taking herbal remedies . Deutsche Medizinische Wochenschrift, 123, 1410-1414.

Tinsley, J.A. (1999). The hazards of psychotropic herbs. Minnesota Medicine, 82 (5), 29-31.

Uebelhack, R. , Franke, L. , & Schewe, H.J. (1998). Inhibition of platelet MAO-B by kava pyrone-enriched extract from piper methysticum forster (kava kava). Pharmacopsychiatry , 31, 187-192.

Volz, H.P. , & Kieser, M. (1997). Kava kava extract WS 1490 versus placebo in anxiety disorders: A randomized placebo-controlled 25 week outpatient trial. Pharmacopsychiatry, 30, 1-5.

Wagner J. , Wagner, M.L. , & Hening, W.A. (1998). Beyond benzodiazepines: Alternative pharmacologic agents for the treatment of insomnia. Annals of Pharmacotherapy , 32, 680-691.

Wetterberg, L. (1999). Melatonin and clinical application. Reproduction, Nutrition, Development, 39, 367-382.

Willey, L.B. , Mady, S.P. , Cobaugh, D.J. , & Wax, P.M. (1995). Valerian overdose: A case report. Veterinary and Human Toxicology, 37, 364-365.

Wong, A.H. , Smith, M. , & Boon, H.S. (1998). Herbal remedies in psychiatric practice. Archives of General Psychiatry, 55, 1033-1044.